Subsequent Events

3 Months Ended

Mar. 31, 2018

Subsequent Events [Abstract]

Subsequent Events

17. Subsequent Events

On April 26, 2018, we announced a three-party collaboration with Roche and Dian Diagnostics Group, Co., Ltd. (“Dian”) to integrate our comprehensive genomic profiling (“CGP”) assays into clinical patient care in mainland China. Under the collaboration, Dian becomes the exclusive clinical sequencing partner in China for FoundationOne, FoundationACT and FoundationOneHeme, enabling the delivery of molecular information services by these tests for patients in China. Roche will maintain commercial exclusivity for our molecular information services in China, and in cooperation with Dian will continue its current in-county activities to support the broad integration of CGP into clinical care.